Symptom Burden of Immune Checkpoint Inhibitor Therapy: Development of a Patient-Reported Outcome Measure
Oncology Nursing Forum · 04.05.2026
DOI: 10.1188/26.onf.e26535303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Nursing Forum, online erschienen am 04.05.2026. Verfasst von Loretta A Williams und 5 weiteren Autor:innen. Beteiligte Einrichtung: Loretta A. Williams. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Immune Checkpoint Inhibitors, Quality of Life, Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Loretta A. Williams.
- Meagan Whisenant.
- Shu-En Shen.
- Donna Malveaux.
- Darcy Ponce.
- Mehmet Altan.
Zitieren
APA
Williams, L. A., Whisenant, M., Shen, S. E., Malveaux, D., Ponce, D., & Altan, M. (2026). Symptom Burden of Immune Checkpoint Inhibitor Therapy: Development of a Patient-Reported Outcome Measure. Oncology Nursing Forum. https://doi.org/10.1188/26.onf.e26535303
Vancouver
Williams LA, Whisenant M, Shen SE, Malveaux D, Ponce D, Altan M. Symptom Burden of Immune Checkpoint Inhibitor Therapy: Development of a Patient-Reported Outcome Measure. Oncology Nursing Forum. 2026. doi:10.1188/26.onf.e26535303
BibTeX
@article{Williams2026,
author = {Williams, Loretta A and Whisenant, Meagan and Shen, Shu-En and Malveaux, Donna and Ponce, Darcy and Altan, Mehmet},
title = {Symptom Burden of Immune Checkpoint Inhibitor Therapy: Development of a Patient-Reported Outcome Measure},
journal = {Oncology Nursing Forum},
year = {2026},
doi = {10.1188/26.onf.e26535303}
}
EUVIMED